A phase 1, open-label, single-dose, multiple-dose study to evaluate the safety, tolerability, and pharmacokinetic characteristics of naldemedine in healthy Chinese adult subjects
Active, not recruitingChiCTR2300076608
The Second Hospital of Anhui Medical UniversityOpioid-induced constipation
Start: 2022-07-01Updated: 2023-10-16